[go: up one dir, main page]

TW200501951A - Treatment of neuropathic pain, fibromyalgia or rheumatoid arthritis - Google Patents

Treatment of neuropathic pain, fibromyalgia or rheumatoid arthritis

Info

Publication number
TW200501951A
TW200501951A TW093117155A TW93117155A TW200501951A TW 200501951 A TW200501951 A TW 200501951A TW 093117155 A TW093117155 A TW 093117155A TW 93117155 A TW93117155 A TW 93117155A TW 200501951 A TW200501951 A TW 200501951A
Authority
TW
Taiwan
Prior art keywords
fibromyalgia
treatment
rheumatoid arthritis
neuropathic pain
gaboxadol
Prior art date
Application number
TW093117155A
Other languages
Chinese (zh)
Inventor
Bjarke Ebert
Connie Sanchez
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of TW200501951A publication Critical patent/TW200501951A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

The present invention relates to the use of Gaboxadol for the preparation of medicaments useful for the treatment of neuropathic pain, fibromyalgia or rheumatoid arthritis.
TW093117155A 2003-06-25 2004-06-15 Treatment of neuropathic pain, fibromyalgia or rheumatoid arthritis TW200501951A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA200300955 2003-06-25

Publications (1)

Publication Number Publication Date
TW200501951A true TW200501951A (en) 2005-01-16

Family

ID=42778303

Family Applications (1)

Application Number Title Priority Date Filing Date
TW093117155A TW200501951A (en) 2003-06-25 2004-06-15 Treatment of neuropathic pain, fibromyalgia or rheumatoid arthritis

Country Status (2)

Country Link
AR (1) AR044884A1 (en)
TW (1) TW200501951A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11123332B2 (en) 2018-11-21 2021-09-21 Certego Therapeutics Inc. Gaboxadol for reducing risk of suicide and rapid relief of depression
US11597726B2 (en) 2020-05-20 2023-03-07 Certego Therapeutics Inc. Ring deuterated gaboxadol and its use for the treatment of psychiatric disorders

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11123332B2 (en) 2018-11-21 2021-09-21 Certego Therapeutics Inc. Gaboxadol for reducing risk of suicide and rapid relief of depression
US11597726B2 (en) 2020-05-20 2023-03-07 Certego Therapeutics Inc. Ring deuterated gaboxadol and its use for the treatment of psychiatric disorders

Also Published As

Publication number Publication date
AR044884A1 (en) 2005-10-05

Similar Documents

Publication Publication Date Title
IL175770A0 (en) Novel use of peptide compounds for treating central neuropathic pain
TW200508214A (en) Novel compounds
EG24978A (en) Fluoro substituted cycloalkanoindoles, compositions containing such compounds and methods of treatment.
TW200508201A (en) Novel process for the preparation of roflumilast
EP2270048A3 (en) Anti-NGF antibodies and methods using same
SI1480961T1 (en) Glutaminyl based dpiv inhibitors
UA86599C2 (en) Substituted benzimidazole-, benztriazole- and benzimidazolone-о-glucosides
HK1094421A1 (en) (S)-2-n-propylamino-5-hydroxytetralin as a d3-agonist
NO20070440L (en) Treatment of neuropathic pain, fibromyalgia or rheumatoid arthritis
MY128924A (en) Novel compounds
MX2009011346A (en) Tapentadol for treating pain from arthritis.
AU2003258145A8 (en) Substituted phenylindoles for the treatment of hiv
TW200504402A (en) Antimicrobial lenses, processes to prepare them and methods of their use
MXPA06004308A (en) Isopentyl carboxanilides for combating undesired micro-organisms.
MXPA04000446A (en) Substituted 4-aminocyclohexanols.
MXPA06002315A (en) Erg channel openers for the treatment of cardiac arrhythmias.
ATE314043T1 (en) DERIVATIVES OF AZA SPIR COMPOUNDS FOR THE TREATMENT OF PAIN
TW200501951A (en) Treatment of neuropathic pain, fibromyalgia or rheumatoid arthritis
MXPA04004090A (en) Substituted 1h-quinolin-2-one compounds.
UA87117C2 (en) Use of peptide compounds for treatment of central neuropatic pain
MXPA04000272A (en) Substituted 4-aminocyclohexanol derivatives.
MXPA05012742A (en) Hair treatment compositions.
HRP20050611A2 (en) Combination medicament
GB0330049D0 (en) The treatment of neuropathic pain conditions
AU2003266960A1 (en) Composition for the treatment of pain, especially for the treatment of articular pain